作者: Mark J Mannis
DOI:
关键词:
摘要: Purpose Bacterial keratitis is an ocular infection with the potential to cause significant visual impairment. Increasing patterns of antibiotic resistance have necessitated development new antimicrobial agents for use in bacterial and other serious infections. With a view exploring novel peptides management infection, we performed series experiments using synthetic designed eradication common ophthalmic pathogens. Methods Experiments were three clinical isolates--Pseudomonas aeruginosa, Staphylococcus aureus, epidermidis--in experimental settings: (1) vitro controlled system 10 mM sodium phosphate buffer, (2) modified chondroitin sulfate-based corneal preservation media (Optisol), (3) vivo animal model (rabbit) simulating keratitis. In all cases, outcomes measured by quantitative microbiological techniques. Results The candidate (CCI A, B, C COL-1) produced total reduction test pathogens buffered saline. Optisol, effective against S epidermidis at temperatures, demonstrated augmented activity 23 degrees gram-positive organisms, but ineffective P aeruginosa. addition EDTA medium killing aeruginosa made no difference organisms. rabbit Pseudomonas keratitis, COL-1 neither nor microbicidal efficacy appeared very narrow dosage range, outside which it be toxic surface. Conclusion Our data indicate that tested not vivo. age increasing resistance, peptides, developed over millions years as innate defense mechanisms plants animals, may topical severe However, modifications drug delivery systems, or both, will necessary application.